$TIL Cashflow Statement | Understand Stock

$TIL

$5.84 +$0.27 (4.85%) Close

$TIL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on issuance of Series A convertible preferred stock
Stock-based compensation
Non-cash lease expense
Foreign exchange remeasurement (gain) loss
Impairment of goodwill and intangible assets
Impairment of fixed assets
Impairment of property, plant and equipment
Impairment of right-of-use assets
Change in fair value of contingent consideration
Depreciation
Restructuring costs
In-process research and development expenses
Accretion on invested securities
Non-cash interest expense
Non-cash loss on debt extinguishment
Change in fair value of derivative financial instrument
Loss on disposals of property and equipment
Other, net
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Other long-term assets
Accrued rent receivable
Accounts payable
Operating lease liabilities
Long-term liabilities
Accrued restructuring costs
Accrued expenses and other current liabilities

Net cash used in operating activities
Cash flows from investing activities:
Purchase of marketable securities
Maturities of marketable securities
Purchases of property, plant and equipment
Business acquisition, net of cash acquired
Cash received from held for sale assets
Cash received from asset disposals
Acquired in-process research and development
Cash received from termination of derivative financial instrument
Purchase of derivative financial instrument
Net cash provided by investing activities

Cash flows from financing activities:
Proceeds from initial public offering, net of issuance costs
Proceeds from issuance of convertible preferred stock, net of issuance costs
Principal payments on loan
Proceeds on Construction Loan Agreements
Proceeds from the 2024 Loan
Other financing activities
Principal payments on Construction Loans
Proceeds from at-the-market offering, net of $0.3 million in issuance costs
Proceeds from exercise of stock options
2024 Loan agreement closing costs
Net cash provided by financing activities

Net (decrease) increase in cash, cash equivalents, and restricted cash
Effect of exchange rate changes on cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash—beginning of period
Cash, cash equivalents and restricted cash—end of period
Supplemental disclosure of cash flow information:
Cash paid for interest
Conversion of preferred stock to common stock upon IPO
Purchases of property, plant and equipment in accounts payable and accrued expenses and other current liabilities
Business acquisition through issuance of common stock and contingent consideration payable
Deferred offering costs in accrued expenses and other current liabilities

Comments